Objectives: To evaluate the safety of outpatient treatment of patients with very low-risk pulmonary embolism (PE), and the satisfaction and quality of life of this management. Methods: An experimental study of routine clinical practice will be carried out in which 300 consecutive hemodynamically stable patients with acute symptomatic PE will be included, who meet all the inclusion criteria and none of the exclusion criteria. All patients included in the study will be treated on an outpatient basis, that is, they will be discharged within the first 24 hours of the diagnosis of PE in the Emergency Department. The Computerized Registry of Thromboembolic Disease RIETE (Registro Informatizado de Enfermedad TromboEmbólica) will be used to collect the data in electronic case report form (CRF) and ensure the quality of the data. Setting: Emergency, Pneumology and Internal Medicine Services of 10 Spanish hospitals. Analysis: An intention-to-treat (ITT) analysis will be performed on all patients who sign the informed consent and are included in the study (regardless of whether or not they receive the assigned strategy). Additionally, an analysis of all patients who are treated on an outpatient basis without deviations or violations of the protocol will be performed. The primary outcome considered will be the composite of recurrent PE, major bleeding, or death from any cause during the first 30 days after enrollment in the study. Patient satisfaction and quality of life will be considered as secondary outcomes.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
300
All patients included in the study will be treated on an outpatient basis, that is, they will be discharged within the first 24 hours of the diagnosis of PE in the Emergency Department.
Hospital Clinic
Barcelona, Spain
NOT_YET_RECRUITINGHospital General Universitari de Castelló
Castelló, Spain
NOT_YET_RECRUITINGHospital Universitario Donostia
Donostia / San Sebastian, Spain
NOT_YET_RECRUITINGHospital Universitario Virgen de las Nieves
Granada, Spain
NOT_YET_RECRUITINGHospital San Pedro
Logroño, Spain
NOT_YET_RECRUITINGClínica Universidad Navarra
Madrid, Spain
NOT_YET_RECRUITINGHospital Gregorio Marañón
Madrid, Spain
NOT_YET_RECRUITINGHospital Ramón y Cajal
Madrid, Spain
RECRUITINGComplejo Hospitalario Virgen del Rocío
Seville, Spain
NOT_YET_RECRUITINGHospital Doctor Peset
Valencia, Spain
NOT_YET_RECRUITINGComposite of recurrent pulmonary embolism (PE), major bleeding, or death from any cause.
The primary outcome considered will be the composite of recurrent PE, major bleeding, or death from any cause during the first 30 days after enrollment in the study.
Time frame: 30 days
Satisfaction of the patients
The satisfaction of the patients will be evaluated on day 30 of follow-up using the Patient Satisfaction Questionnaire (PSQ-18).
Time frame: 30 days
Quality of life of the patients
Quality of life of the patients will be evaluated on day 30 of follow-up using the Pulmonary Thromboembolism Quality of Life Questionnaire (PEmb-Qol).
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.